Private Advisor Group LLC cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Rating) by 26.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,850 shares of the exchange traded fund’s stock after selling 14,066 shares during the period. Private Advisor Group LLC’s holdings in SPDR S&P Biotech ETF were worth $815,730,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in XBI. EWG Elevate Inc. bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $26,000. MADDEN SECURITIES Corp bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $33,000. SRS Capital Advisors Inc. bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $41,000. Parkside Financial Bank & Trust bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $47,000. Finally, Aptus Capital Advisors LLC boosted its holdings in SPDR S&P Biotech ETF by 56.4% during the third quarter. Aptus Capital Advisors LLC now owns 696 shares of the exchange traded fund’s stock worth $55,000 after buying an additional 251 shares in the last quarter.
SPDR S&P Biotech ETF Stock Performance
Shares of NYSEARCA:XBI opened at $74.95 on Tuesday. The stock has a market capitalization of $7.04 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 1-year low of $61.78 and a 1-year high of $97.19. The company has a 50 day moving average price of $83.74 and a 200 day moving average price of $82.26.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Get a free copy of the StockNews.com research report on SPDR S&P Biotech ETF (XBI)
- 3 High Yields On Breakout Watch With Analyst Tailwinds
- Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
- 3 Financials The Insiders Are Buying
- Can Carnival Cruise Lines Set Sail For New Highs?
- If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Rating).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
